Please Log In to Access This Page
January 30 - February 1, 2011
Houston, TX
Ensuring Uninterrupted Manufacturing Operations through Strict FDA Compliance, Cohesive Design Plans and Quality Control, while Enhancing Operational Efficiency & Excellence
ABOUT THE FORUM
Although many industries face challenges in manufacturing their products and technologies, there is no industry more complex in their manufacturing processes than the pharmaceutical and medical device industries. Facing hurdles that range from tremendous regulatory restrictions, product sterility and component stability, through to efficiency and cost-reduction concerns, these industries are constantly working to innovate and tighten operations. Building on Q1 productions' successful series of pharmaceutical and medical device regulatory, quality and manufacturing conferences, the Pharmaceutical and Medical Device Manufacturing Forum will bring together key industry leaders to discuss and debate current trends and opportunities in enhancing the manufacturing operations of both pharmaceutical and medical device organizations.
Through joint keynote presentations that will highlight common trends, through to stand-alone programs for each industry, this program will provide participants with a wealth of information and strategies that can be immediately applied within their organizations. For provider partners, the opportunity to network with high ranking executives from both the pharmaceutical and medical device industry will enable them an unparalleled opportunity for business development.
Joint keynote presentations will highlight recent trends and topics that will be of concern to the entire forum audience, and will range from topics on trends in FDA oversight, to new opportunities and challenges presented by US Healthcare Reform. Although for many organizations health policy is generally overseen by policy and government affairs executives, members of the manufacturing team are anxious to understand how policy changes will impact potential forecasting and manufacturing requirements. Panel discussions bringing together government representatives and industry experts will highlight many of the challenges and opportunities that lie ahead.
Each industry will also have a unique and dedicated program agenda, enabling attendees to delve into specific issues based on their individual industry sectors. Sessions that have been identified as critical to the pharmaceutical and biotechnology industries will span the entire manufacturing process, from discussions on QbD (Quality by Design), through to product coding, packaging and security concerns. Lean and green manufacturing for the pharmaceutical and biotechnology industries will also be discussed, as organizations strive to become not only more efficient in their manufacturing, but also look to reduce waste, and increase their environmental stewardship. Medical device and diagnostic manufacturers will also have a dedicated program covering the entirety of the manufacturing process, with sessions highlighting changes in FDA 510(k) manufacturing equivalence concerns, through to ISO guidelines so critical to organizations manufacturing abroad.
Throughout each agenda, sessions will bring together leaders in the industry to truly focus on the cutting edge challenges that they face in bringing safe, effective and consistent therapies and technologies to the healthcare industry. From initial product design and manufacturing considerations, through to regulatory, packaging and tracking concerns, this program will address the entire spectrum of the manufacturing process, offering a unique setting for both delegates and provider partners to network, share and learn more about this exciting industry.
